Marsh McLennan (MRSH) valuation
Marsh McLennan P/E ratio history
Marsh McLennan trades at 24.0 times its earnings over the last twelve months and 17.9 times the earnings analysts expect over the next twelve.
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Marsh McLennan valuation against its peers
| Company | Market value | P/E | Forward P/E |
|---|---|---|---|
| Marsh McLennanMRSH | $95.7B | 24.0 | 17.9 |
| Travelers Companies (The)TRV | $82.6B | 10.4 | 12.2 |
| Arthur J. GallagherAJG | $70.9B | 45.8 | 19.8 |
| AonAON | $68.2B | 17.6 | 16.2 |
| ProgressivePGR | $135B | 11.6 | 13.7 |
| AllstateALL | $66.9B | 5.2 | 8.1 |
| ChubbCB | $140B | 12.8 | 12.4 |
| MetLifeMET | $64.4B | 19.1 | 9.4 |
| AflacAFL | $63.1B | 13.4 | 16.9 |
| Peer median | 13.1 | 13.1 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: MRSH returns
No forecast, no recommendation. This page describes Marsh McLennan from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.